Browsing by Author "Morancho Armisen, Beatriz"
Now showing items 1-4 of 4
-
HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
Gorbatenko, Andrej; Søkilde, Rolf; Sorensen, Ester E.; Newie, Inga; Persson, Helena; Morancho Armisen, Beatriz; Arribas López, Joaquin Vicente (Nature Publishing Group, 2019-03-04) -
The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1
Nadal Serrano, Mercedes; Morancho Armisen, Beatriz; Escriva de Romaní Muñoz, Santiago Ignacio; Luque García, Antonio; Escorihuela Baez, Marta; Espinosa Bravo, Martin; Peg Camara, Vicente; Cortés Castan, Javier; Arribas López, Joaquin Vicente; Bernadó Morales, Cristina; Saura Manich, Cristina (MDPI, 2020-03-13) -
The target antigen determines the mechanism of acquired resistance to T cell-based therapies
Morancho Armisen, Beatriz; Román Alonso, Macarena; Ovejero Romero, Pablo; Escorihuela Baez, Marta; Arribas López, Joaquin Vicente; Arenas Lahuerta, Enrique Javier; Martínez-Sabadell, Alex; Rius Ruiz, Irene (Cell Press, 2022-10-18) -
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
Duro Sánchez, Santiago; Nadal Serrano, Mercedes; Lalinde-Gutiérrez, Marta; Morancho Armisen, Beatriz; Escorihuela Baez, Marta; Pérez-Ramos, Sandra; Escriva de Romaní Muñoz, Santiago Ignacio; Gandullo Sánchez, Lucía; Rodilla Benito, Verónica; Cortés Castan, Javier; Arribas López, Joaquin Vicente; Bernadó Morales, Cristina; Arenas Lahuerta, Enrique Javier; Saura Manich, Cristina (American Association for Cancer Research, 2022-12-16)